Vagueness and costs of the pause on gain-of-function (GOF) experiments on pathogens with pandemic potential, including influenza virus

mBio

Volumn 5, Issue 6, 2014, Pages

  Imperiale, Michael J ^a   Casadevall, Arturo ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS ANTHRACIS; BACTERIAL SPORE; COST; EDITORIAL; EXPERIMENT; FUNDING; GAIN OF FUNCTION EXPERIMENT; GOVERNMENT; HUMAN; INFLUENZA VIRUS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; POSTDOCTORAL EDUCATION; RNA VIRUS; SAFETY; SARS CORONAVIRUS; VIRAL TROPISM; VIRUS TRANSMISSION; VIRUS VIRULENCE; GENETIC RECOMBINATION; GENETICS; HEALTH CARE POLICY; IMMUNOLOGY; MEDICAL RESEARCH; ORTHOMYXOVIRIDAE; PANDEMICS; PATHOGENICITY; TRENDS; UNITED STATES; VIRULENCE;

ORTHOMYXOVIRIDAE;

BIOMEDICAL RESEARCH; HEALTH POLICY; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; ORTHOMYXOVIRIDAE; PANDEMICS; RECOMBINATION, GENETIC; SARS VIRUS; UNITED STATES; VIRULENCE;

EID: 84920911065     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02292-14     Document Type: Editorial

References (14)

1. Casadevall A, Imperiale MJ. 2014. Risks and benefits of gain-of-function experiments with pathogens of pandemic potential, such as influenza virus: a call for a science-based discussion. mBio 5(4):e01730-14. http://dx.doi.org/10.1128/mBio.01730-14.
2. Casadevall A, Howard D, Imperiale MJ. 2014. An epistemological perspective on the value of gain-of-function experiments involving pathogens with pandemic potential. mBio 5(5):e01875-14. http://dx.doi.org/10.1128/mBio.01875-14.
3. U.S. Office of Science and Technology Policy. 17 October 2014, posting date. Doing diligence to assess the risks and benefits of life sciences gainof-function research. http://www.whitehouse.gov/blog/2014/10/17/doing-diligence-assess-risks-and-benefits-life-sciences-gain-function-research.
4. Wain-Hobson S. 2014. The irrationality of GOF avian influenza virus research. Front Public. Health 2:77. http://dx.doi.org/10.3389/fpubh.2014.00077.
5. Malakoff D. 2012. H5N 1. Flu controversy spurs research moratorium. Science 335:387–389. http://dx.doi.org/10.1126/science.335.6067.387.
6. Malakoff D. 2013. Avian influenza. H5N1 researchers ready as moratorium nears end. Science 339:16–17. http://dx.doi.org/10.1126/science.339.6115.16.
7. Berg P, Baltimore D, Brenner S, Roblin RO, Singer MF. 1975. Summary statement of the Asilomar conference on recombinant DNA molecules. Proc. Natl. Acad. Sci. U. S. A. 72:1981–1984. http://dx.doi.org/10.1073/pnas.72.6.1981.
8. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534–1541. http://dx.doi.org/10.1126/science.1213362.
9. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420–428. http://dx.doi.org/10.1038/nature10831.
10. Casadevall A, Dermody TS, Imperiale MJ, Sandri-Goldin RM, Shenk T. 2014. On the need for a national board to assess dual use Research of Concern. J. Virol. 88:6535– 6537. http://dx.doi.org/10.1128/JVI.00875-14.
11. Kaiser J. 2014. Biosecurity. U.S. halts two dozen risky virus studies. Science 346:404. http://dx.doi.org/10.1126/science.346.6208.404.
12. Greenfieldboyce N. 7 November 2014, release date. How a tilt toward safety stopped a scientist’s research. Shots: health news from NPR. http://www.npr.org/blogs/health/2014/11/07/361219361/how-a-tilt-toward-safety-stopped-a-scientists-virus-research.
13. Schultz-Cherry S, Webby RJ, Webster RG, Kelso A, Barr IG, McCauley JW, Daniels RS, Wang D, Shu Y, Nobusawa E, Itamura S, Tashiro M, Harada Y, Watanabe S, Odagiri T, Ye Z, Grohmann G, Harvey R, Engelhardt O, Smith D, Hamilton K, Claes F, Dauphin G. 2014. Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness. MBio 5(6):e02430-14. http://dx.doi.org/10.1128/mBio.02430-14.
14. Davis CT, Chen L-M, Pappas C, Stevens J, Tumpey TM, Gubareva LV, Katz JM, Villanueva JM, Donis RO, Cox NJ. 2014. Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecularbased surveillance and pandemic preparedness. MBio 5(6):e02431-14. http://dx.doi.org/10.1128/mBio.02431-14.